RESEARCH PLANS

Germany's Scholz stresses need to speed up approvals process for pharma

The central thing that we have to make possible is faster approvals processes. This applies to factories ... but just as much for new medicines, research plans and also for the use of data when it is for research: Scholz while adding that his government planned concrete legislative proposals to this effect in a very short space of time.